Samsung Bioepis Launches Biosimilar for Stelara in the U.S.
Seoul: Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, announced the launch of its biosimilar product for Stelara, an autoimmune disease treatment, in
Seoul: Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, announced the launch of its biosimilar product for Stelara, an autoimmune disease treatment, in
Seosan: The operations of LG Chem and Lotte Chemical plants at an industrial complex in the central city of Seosan were halted due to a
Gyeryong: South Korea’s Navy chief held talks with his Turkish counterpart Tuesday to discuss ways to bolster their bilateral defense and arms cooperation, officials said.
Seoul: SK Biopharmaceuticals Co. announced on Tuesday that it has finalized an agreement to procure a high-purity radioactive isotope from Belgium’s PanTera. This acquisition is
Seoul: The annals of South Korean history are marked by significant events that have shaped the nation’s trajectory. From pivotal political decisions to remarkable individual
Seoul: The annals of South Korean history are marked by significant events that have shaped the nation’s trajectory. From pivotal political decisions to remarkable individual
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
Â
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
This diverse coverage showcases the site’s commitment to broad-spectrum news dissemination, aiming to engage a diverse audience with varied interests across multiple disciplines.